Biotest

News

Grifols files drug for rare bleeding disorder in the US

Grifols has filed for FDA approval of its new drug for bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class US launch.

News

Grifols eyes first place in US fibrinogen concentrate market

Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatmen

News

Simple blood test could aid in global TB fight

A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks